What proportion of patients with heart failure and preserved ejection fraction are eligible for empagliflozin?

aDepartment of Cardiology, Policlinico Casilino

bDepartment of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University, Rome, RomeItaly

Correspondence to Luca Monzo, MD, PhD, Department of Cardiology, Policlinico Casilino, Via Casilina 1049, 00169 Rome, Italy Tel: +39 623188406; fax: +39 623188410; e-mail: [email protected]

Received 1 December, 2021

Revised 26 April, 2022

Accepted 27 April, 2022

留言 (0)

沒有登入
gif